Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for STRATA Skin Sciences (SSKN) over the last 10 years, with Q3 2025 value amounting to $9000.0.

  • STRATA Skin Sciences' Change in Account Payables rose 10076.79% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 17877.55%. This contributed to the annual value of -$954000.0 for FY2024, which is 85400.0% down from last year.
  • As of Q3 2025, STRATA Skin Sciences' Change in Account Payables stood at $9000.0, which was up 10076.79% from $103000.0 recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Change in Account Payables ranged from a high of $1.1 million in Q1 2022 and a low of -$1.2 million during Q3 2024
  • In the last 5 years, STRATA Skin Sciences' Change in Account Payables had a median value of $128000.0 in 2022 and averaged $4263.2.
  • As far as peak fluctuations go, STRATA Skin Sciences' Change in Account Payables plummeted by 58359.38% in 2023, and later surged by 30714.29% in 2024.
  • Over the past 5 years, STRATA Skin Sciences' Change in Account Payables (Quarter) stood at $342000.0 in 2021, then crashed by 376.02% to -$944000.0 in 2022, then surged by 117.8% to $168000.0 in 2023, then soared by 307.14% to $684000.0 in 2024, then plummeted by 98.68% to $9000.0 in 2025.
  • Its Change in Account Payables was $9000.0 in Q3 2025, compared to $103000.0 in Q2 2025 and $362000.0 in Q1 2025.